ST
HAE icon

Smithfield Trust’s Haemonetics HAE Stock Holding History

Smithfield Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-161
Closed -$16K – 1063
2020
Q1 		$16K Sell
161
-409
-72% -$44.4K ﹤0.01% 608
2019
Q4 		$65K Hold
570
– – 0.01% 476
2019
Q3 		$72K Buy
570
+90
+19% +$11.4K 0.01% 461
2019
Q2 		$58K Buy
+480
New +$47.2K 0.01% 495

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Smithfield Trust's HAE Position: Q2 2020 in Review

Smithfield Trust sold out of Haemonetics (HAE) in Q2 2020, closing a stake of 161 shares — an estimated $16K sold.

Smithfield Trust first reported a position in HAE in Q2 2019 and held it in 4 quarters. The position peaked at $72K in Q3 2019. 285 funds tracked by Wall St. Rank hold HAE as of Q2 2020.

  • Smithfield Trust reported no remaining Haemonetics position as of Q2 2020 after selling out during the quarter.
  • Smithfield Trust sold 161 Haemonetics shares in Q2 2020, an estimated $16K.
  • Smithfield Trust first reported a position in Haemonetics in Q2 2019 and held it in 4 quarters.
  • Smithfield Trust's Haemonetics position peaked at $72K in Q3 2019.
  • 285 funds tracked by Wall St. Rank held Haemonetics as of Q2 2020.

Based on Smithfield Trust's 13F filing for Q2 2020, filed 14 Aug 2020.